Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
17 Nov 2026AstraZenecaUnited States, Argentina, AustraliaA Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCPhase 2Not Yet Recruiting17 Nov 2026SensorionFranceA Clinical Trial With SENS-601, Injected With SPHYNX Administration System, in the Pediatric Population Presenting With Hearing Loss Related to Pathogenic Variation(s) of GJB2 GenePhase 1, Phase 2Recruiting10 Nov 2026Boehringer IngelheimBelgium, France, GermanyA Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigPhase 3Not Yet Recruiting10 Nov 2026Eli Lilly and CompanyUnited States, France, JapanA Study of LY4336619 in Adult Participants With Advanced Solid TumorsPhase 1Not Yet Recruiting10 Nov 2026SuisselleFranceEffectiveness and Safety of Cellbooster Glow in Healthy SubjectsNot applicableNot Yet Recruiting10 Nov 2026SuisselleFranceEffectiveness and Safety of Cellbooster Hair in Healthy SubjectsNot applicableNot Yet Recruiting9 Nov 2026Boston Scientific CorporationCroatia, Czechia, FranceThe Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE NAV™ ULTRA Pulsed Field Ablation Catheter in the Treatment of Atrial FibrillationNot applicableNot Yet Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting2 Nov 2026Replior ABFranceObservational Analytical Validation Study of the Replior ScratchSenseRecruiting2 Nov 2026SolsiusFranceContinuous Monitoring of Plantar Temperature Variations Using Connected Insoles and a Mobile Application for Diabetic Foot.Not applicableRecruiting29 Oct 2026AxomoveFranceEvaluation of the Axomove Therapy Medical Device to Facilitate Adapted Physical Activity for Patients With ObesityNot applicableNot Yet Recruiting29 Oct 2026Laboratoires ARIONFranceEvaluation of the Performance and Safety of the Monobloc® - Silicone SoftOne® Breast Implants at 10 YearsActive Not Recruiting28 Oct 2026Eli Lilly and CompanyUnited States, Argentina, AustraliaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskPhase 3Not Yet Recruiting28 Oct 2026Minerais SASFranceSUVY VerSus SAccharose (SUVISA)Not applicableNot Yet Recruiting27 Oct 2026Swedish Orphan BiovitrumBrazil, Canada, FinlandA Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsPhase 3Recruiting21 Oct 2026FASTENFranceFasten Onco Digital Therapy During Neoadjuvant Treatment for Triple-Negative Breast CancerNot applicableNot Yet Recruiting21 Oct 2026WockhardtBosnia and Herzegovina, Bulgaria, CroatiaCefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaPhase 3Not Yet Recruiting// How AOS uses this